SYN1484798

SynDRA canonical compound SYN1484798 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	IGF1R
Mechanism of action	insulin growth factor receptor inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

ABCG2

Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)

CSNK2A1
CSNK2A2
CSNK2A3
CSNK2B

Cross-references

PubChem CID: 71496459
ChEMBL: CHEMBL3353412

Synonyms

AZ7550
Osimertinib metabolite M3
NI2ZUZ6F4O
AZ 7550
UNII-NI2ZUZ6F4O
RefChem:162171
Osimertinib Impurity 4
orb1708049
SCHEMBL14661086
SCHEMBL29860673
SCHEMBL30379658
ZROCWKZRGJYPTG-UHFFFAOYSA-N
EX-A6199
HY-B0794
WGC37399
BDBM50029687
MFCD28902295
AKOS040740713
AZ7550?
CS-8145
AC-35817
DA-50841
TS-07927
T13564

Look up SYN1484798 in the interactive SynDRA portal →